Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.

Di Carli, Marcelo F

Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO. [electronic resource] - Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology Feb 2018 - 157-163 p. digital

Publication Type: Journal Article

1532-6551

10.1007/s12350-017-1035-4 doi


Atherosclerosis--diagnostic imaging
Cardiology--methods
Constriction, Pathologic--diagnostic imaging
Coronary Angiography
Coronary Artery Disease--diagnostic imaging
Coronary Circulation
Humans
Myocardial Perfusion Imaging
Nuclear Medicine
Positron-Emission Tomography
Risk Assessment
Societies, Medical
United States